Daniel González-Padilla

13PUBLICATIONS
51CO-AUTHORS
Business ethicsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersClinimetrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 15, 2026
Analysis of European Association of Urology Guidelines 2023 and its adherence to GRADE methodology.

|Jul 28, 2026
Enhanced Endoscopic Imaging Technologies in Upper Urinary Tract Urothelial Tumors: Implications for Kidney-Sparing Surgery-A Narrative Review.

|May 13, 2026
Diagnostic Role and Clinical Impact of Zr-Girentuximab PET-CT for the Diagnosis and Treatment of Clear-Cell Renal Cell Carcinoma.

|Mar 03, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.

Ana Fernández-Mardomingo, Jose Daniel Subiela, Alberto Artiles Medina

|Aug 29, 2025
Defining statistical cure in patients with T1 high-grade non-muscle-invasive bladder carcinoma treated with BCG immunotherapy.

José Daniel Subiela, Irene de la Parra, Javier Taborda

|Oct 16, 2024
Muscle-Invasive Bladder Cancer in Non-Curative Patients: A Study on Survival and Palliative Care Needs.

Félix Guerrero-Ramos, Daniel Antonio González-Padilla, Santiago Pérez-Cadavid

Pageof 3

Frequent Collaborators

6 joint publications

José Daniel Subiela

4 joint publications

Felipe Villacampa-Aubá

3 joint publications

José Medina-Polo

2 joint publications

Simone Albisinni